Multiple-order singularity expansion method

Autor: I Ben Soltane, R Colom, F Dierick, B Stout, N Bonod

Publikováno v: New Journal of Physics, Vol 25, Iss 10, p 103022 (2023)

Physical systems and signals are characterized by complex functions of the frequency in the harmonic domain. The extension of such functions to the complex frequency plane, and in particular expansions and factorized forms of the harmonic-domain func

Externí odkaz: https://doaj.org/article/193f047e10b14515ad55f93659af2498

Spectral expansions of open and dispersive optical systems: Gaussian regularization and convergence

Autor: B Stout, R Colom, N Bonod, R C McPhedran

Publikováno v: New Journal of Physics, Vol 23, Iss 8, p 083004 (2021)

Resonant states (RS), also known as quasi-normal modes, arise in spectral expansions of linear response functions of open systems. Manipulation of these spatially ‘divergent’ oscillating functions requires a departure from the usual definitions o

Externí odkaz: https://doaj.org/article/e17d22ff17ec4667afc60db68275c402

Spectral expansions of open and dispersive optical systems: Gaussian regularization and convergence

Autor: R Colom, Ross C. McPhedran, Brian Stout, Nicolas Bonod

Publikováno v: New Journal of Physics
New Journal of Physics, 2021, 23 (8), pp.083004. ⟨10.1088/1367-2630/ac10a6⟩
New Journal of Physics, Institute of Physics: Open Access Journals, 2021, 23 (8), pp.083004. ⟨10.1088/1367-2630/ac10a6⟩

Resonant states (RS), also known as quasi-normal modes, arise in spectral expansions of linear response functions of open systems. Manipulation of these spatially ‘divergent’ oscillating functions requires a departure from the usual definitions o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db8bd856c3c7ada234d07118f89cf3d
https://hal.science/hal-03334586/document

4CPS-090 Efficacy and safety of erlotinib in non-small cell lung cancer

Autor: E Monteagudo Santolaya, L Cebrián Lara, R Colom Moreno, A Sánchez Alcaraz, M Prieto Castelló

Publikováno v: Section 4: Clinical Pharmacy Services.

Background and importance Erlotinib is an epidermal growth factor receptor (EGFR) tyrosine kinase (TKI) inhibitor which strongly inhibits intracellular phosphorylation of EGFR. It is an established treatment for advanced non-small cell lung cancer (N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38f3cad0974bf14b1be965bb47db001f
https://doi.org/10.1136/ejhpharm-2020-eahpconf.191

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.